Sitagliptin And Metformin Hydrochloride Tablet, Film Coated
Product Images NDC 70771-1870

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sitagliptin And Metformin Hydrochloride (NDC 70771-1870). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (D420c4fa 5ed7 412f 8c97 08164c7f6d00 01)

FDA Label Image

Structure (D420c4fa 5ed7 412f 8c97 08164c7f6d00 02)

FDA Label Image

Graph (D420c4fa 5ed7 412f 8c97 08164c7f6d00 03)

FDA Label Image

Graph (D420c4fa 5ed7 412f 8c97 08164c7f6d00 04)

FDA Label Image

Label (D420c4fa 5ed7 412f 8c97 08164c7f6d00 05)

This text provides information about Sitagliptin and Metformin Hydrochloride tablets with a dosage of 50mg/500mg. It includes details on the recommended dosage, storage instructions, and advises to dispense a medication guide to each patient. The tablets are film-coated and should be used within 3 months of opening. The text also mentions the manufacturer as Zydus Lifesciences Ltd.*

FDA Label Image

Label (D420c4fa 5ed7 412f 8c97 08164c7f6d00 06)

This is not readable.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.